Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS: FRTX · Delayed Price · USD
0.901
0.00 (0.06%)
Mar 28, 2024, 11:48 AM EDT - Market open
Fresh Tracks Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1990 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 10.87 | 8.68 | 26.88 | 30.12 | 7.23 | 8.07 | 24.84 | 5.07 | 13.45 | 20.47 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 4.5 | 36.2 | 35.66 | 30.55 | 23.26 | 23.5 | Upgrade
|
Cash & Cash Equivalents | 10.87 | 8.68 | 26.88 | 30.12 | 7.23 | 48.07 | 60.69 | 38.93 | 36.71 | 47.15 | Upgrade
|
Cash Growth | 25.21% | -67.71% | -10.73% | 316.41% | -84.96% | -20.79% | 55.89% | 6.06% | -22.15% | -11.86% | Upgrade
|
Receivables | 0.05 | 0.5 | 0.13 | 0 | 0 | 1.13 | 5.12 | 8.94 | 4.54 | 4.18 | Upgrade
|
Inventory | 0.55 | -0.5 | -0.13 | 0 | 0 | -1.13 | -5.12 | -8.94 | 0 | -4.18 | Upgrade
|
Other Current Assets | 0.09 | 1.4 | 2.72 | 3.42 | 6.24 | 4.93 | 15.82 | 12.25 | 3.25 | 7.36 | Upgrade
|
Total Current Assets | 11.55 | 10.08 | 29.6 | 33.53 | 17.97 | 49.2 | 76.32 | 47.87 | 44.5 | 51.33 | Upgrade
|
Property, Plant & Equipment | 0.03 | 0.12 | 0.12 | 0.1 | 0.18 | 0.1 | 0.61 | 1.17 | 1.87 | 2.64 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 2.39 | 2.21 | 2.05 | 2.05 | 1.97 | Upgrade
|
Intangible Assets | 0 | 1.47 | 0 | 0 | 0 | 0 | 0.7 | 0.81 | 1.3 | 1.66 | Upgrade
|
Other Long-Term Assets | 0 | -1.41 | 0 | 0 | 0 | 0.22 | 0.66 | 0.39 | 0.19 | 0.38 | Upgrade
|
Total Long-Term Assets | 0.03 | 0.19 | 0.12 | 0.1 | 0.18 | 3.15 | 4.18 | 4.42 | 5.42 | 6.65 | Upgrade
|
Total Assets | 11.59 | 10.27 | 29.72 | 33.63 | 18.14 | 52.34 | 80.49 | 52.28 | 49.91 | 57.98 | Upgrade
|
Accounts Payable | 0.41 | 0.57 | 1.61 | 0.57 | 2.25 | 4.07 | 1.21 | 0.33 | 0.73 | 0.23 | Upgrade
|
Deferred Revenue | 0 | 0 | 0 | 0 | 1.8 | 8.12 | 11.7 | 3.02 | 0.25 | 0 | Upgrade
|
Current Debt | 0 | 0.05 | 0.07 | 0.37 | 0.08 | 4.64 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Liabilities | 1.25 | 2.46 | 3.14 | 5.42 | 6.38 | -13.24 | 4 | 3.8 | 3.18 | 4.97 | Upgrade
|
Total Current Liabilities | 1.66 | 3.08 | 4.81 | 6.35 | 10.5 | 3.58 | 16.92 | 7.15 | 4.16 | 5.2 | Upgrade
|
Long-Term Debt | 0 | 0 | 0 | 0.15 | 0.07 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Liabilities | 0 | 0.62 | 0 | 0 | 0 | 1.74 | 0 | 0 | 0.36 | 0.86 | Upgrade
|
Total Long-Term Liabilities | 0 | 0.62 | 0 | 0.15 | 0.07 | 1.74 | 0 | 0 | 0.36 | 0.86 | Upgrade
|
Total Liabilities | 1.66 | 3.08 | 4.81 | 6.5 | 10.57 | 3.58 | 16.92 | 7.15 | 4.52 | 6.06 | Upgrade
|
Total Debt | 0 | 0.05 | 0.07 | 0.51 | 0.15 | 4.64 | 0 | 0 | 0 | 0 | Upgrade
|
Debt Growth | - | -28.99% | -86.50% | 238.41% | -96.74% | - | - | - | - | - | Upgrade
|
Common Stock | 0.06 | 0.03 | 1.19 | 0.54 | 0.09 | 0.22 | 0.22 | 0.11 | 0.92 | 0.9 | Upgrade
|
Retained Earnings | -172.16 | -166.47 | -145.37 | -105.89 | -84.98 | -71.62 | -426.74 | -413.88 | -404.91 | -395.67 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | 0 | -0.03 | 0.27 | 0.12 | 0.03 | 0.04 | -0.01 | Upgrade
|
Shareholders' Equity | 9.93 | 7.19 | 24.91 | 27.14 | 7.57 | 48.76 | 63.58 | 45.14 | 45.39 | 51.92 | Upgrade
|
Total Liabilities and Equity | 11.59 | 10.27 | 29.72 | 33.63 | 18.14 | 52.34 | 80.49 | 52.28 | 49.91 | 57.98 | Upgrade
|
Net Cash / Debt | 10.87 | 8.63 | 26.82 | 29.6 | 11.58 | 39.63 | 60.5 | 35.62 | 36.71 | 43.97 | Upgrade
|
Net Cash / Debt Growth | 25.92% | -67.81% | -9.42% | 155.69% | -70.78% | -34.50% | 69.84% | -2.96% | -16.52% | -12.72% | Upgrade
|
Net Cash Per Share | - | 3.07 | 15.02 | 54.34 | 172.35 | 571.53 | 1478.69 | 1119.95 | 1260.32 | 1559.99 | Upgrade
|
Working Capital | 9.9 | 7.01 | 24.79 | 27.18 | 7.47 | 45.62 | 59.4 | 40.72 | 40.34 | 46.13 | Upgrade
|
Book Value Per Share | - | 2.56 | 13.96 | 49.81 | 112.75 | 703.26 | 1553.92 | 1419.20 | 1558.50 | 1842.12 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.